The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...
Biotech startup Ahammune Biosciences has raised $5 million in Series A funding round led by pi Ventures. The round also ...
The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.
Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has ...
Clinical stage therapeutics startup Ahammune Biosciences, bread brand The Health Factory, proptech startup Flent and ...
Celebrating the success of the Albinism Society of South Africa (ASSA) fundraising event held at Birchwood Hotel recently are ...
Drug maker AbbVie (ABBV) announced Wednesday positive results from a new post-hoc analysis of Phase 3 Studies, demonstrating efficacy ...
Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...
Makeup artist Sarah Tanno painted Gaga’s face with teal eyeshadow, winged liner and red lipstick for the film premiere. In ...
The stuntman-comedian’s tour will stop at the City National Grove of Anaheim on Saturday, Oct. 5, the Balboa Theatre in San ...
"Exfoliation is a critical step in managing uneven skin tones. To help the correcting ingredients within your cleansers, ...
AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...